Dr. Pedro Rafael Cox-Alomar, MD

Dr. Cox-Alomar practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Cox-Alomar's NPI, 1467643213, was assigned on August 7, 2007. Dr. Cox-Alomar graduated from Universidad Central del Caribe School of Medicine in 2007. Dr. Cox-Alomar holds Florida license ME117537.

Dr. Cox-Alomar's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Cox-Alomar's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is Ochsner Health. Dmand AI also links Dr. Cox-Alomar to 5 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cox-Alomar practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Cox-Alomar's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Cox-Alomar is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Cox-Alomar's licenses on file in 4 states: Florida, Louisiana, Puerto Rico and Massachusetts.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Cox-Alomar treats.

CMS data shows 315 Medicare services from Dr. Cox-Alomar across 12 procedure codes in 2024, for 208 Medicare patients. Medicare paid $28,799 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 208 Medicare patients who saw Dr. Cox-Alomar in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cox-Alomar's median patient age at 75, with 47% women.

In 2024, Dr. Cox-Alomar wrote 188 Medicare Part D claims for 56 patients. 74% of them were for generic drugs. CMS names the drug for 109 of them, across 5 drugs with 11 or more claims each, at $21,010 in total drug cost. In 2023, CMS named 45 claims across 2 drugs.

Dr. Cox-Alomar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Cox-Alomar, published from 2018 to 2025. 2019 was the busiest year, with 2. The most frequent topics are Hospital Mortality, Transcatheter Aortic Valve Replacement and Catheterization, Peripheral. Dr. Cox-Alomar has published most often in Cardiovasc Revasc Med. Dr. Cox-Alomar's most frequent co-authors are Jose M. Wiley, MD, Cristina Sanina, MD and Michael Attubato, MD.

CMS Open Payments shows 652 general payments to Dr. Cox-Alomar from 40 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 39% of the total. Edwards Lifesciences Corporation paid the most, $70,379.

Dmand AI lists 2 awards for Dr. Cox-Alomar, most recently Member in 2007.

Dr. Cox-Alomar graduated from Universidad Central del Caribe School of Medicine in 2007. Dr. Cox-Alomar is a member of AOA, ACC and SCAI.

Dr. Cox-Alomar is in network with 7 carriers, including Excellus BlueCross BlueShield, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.